Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors

Lifeline Therapeutics Names James D. Crapo, M.D. to Board of Directors Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Lifeway Foods Reports Year End Results Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003. Lifeway Foods Reports Year End Results Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003. Pure World Announces Results for 2004 Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003. Pure World Announces Results for 2004 Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003. Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each. Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each. Allergy Research Group, Inc. Reports 2004 Results Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003. Allergy Research Group, Inc. Reports 2004 Results Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003. Dynamic Health Products Completes Acquisition of Dynamic Marketing, Inc. Company completes previously announced acquisition. Dynamic Health Products Completes Acquisition of Dynamic Marketing, Inc. Company completes previously announced acquisition. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Country Life Vitamins Inks Joint Venture Agreement With Kikkoman Country Life Vitamins announces a joint venture agreement with Kikkoman under which Country Life will utilize Kikkoman's research and development capabilities and global distribution infrastructure to develop new products and introduce brands to consumers worldwide. Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter. Technology Flavors & Fragrances, Inc. Reports Fourth Quarter and 2004 Results Company reports Q4 sales drop from $3,465,000 to $3,042,000, while gross profit increased to 37.5% from 36.7%, company reports net loss of $921,000, ($.07 per fully diluted share), compared to a net loss of $403,000 ($.03 per fully diluted share) in last year's fourth quarter. Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million. Nutrition 21 Raises $9.6 Million In Convertible Preferred Stock Financing Company has privately placed 9,600 shares of preferred stock and 2,948,662 warrants for an aggregate purchase price of $9.6 million. Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Weider Announces Fiscal 2005 Third Quarter Results Company reports net sales of $65.6 million for Q3, compared to $67.5 million prior year, net income was $1.2 million, or $0.05 per share, compared to $2.6 million, or $0.10 per share the previous year. The company attributes decrease in sales to domestic private label sales and weakness in its Haleko business unit's Multipower and Multaben brands. In other news, the company announced the sale of assets of its Active Nutrition Unit to Weider Global Nutrition for $14.0 million. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Phillips Health, LLC Announces Company Name Change to Healthy Directions, LLC Name change to Healthy Directions, LLC, effective immediately. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. Great Spirit Ventures Acquires The Natural Dentist (R) Great Spirit Ventures, LLC has acquired The Natural Dentist(R), adding company to its portfolio of companies addressing health and wellness. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. NutraCea(R) Executes Definitive Agreement to Merge with RiceX Companies sign definitive agreement to merge with a newly formed subsidiary of NutraCea merging into RiceX, RiceX becoming a wholly owned subsidiary of NutraCea, and the shareholders of RiceX to receive shares of NutraCea common stock in exchange for RiceX shares. Whole Living Reports 2004 Year End Results Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share. Whole Living Reports 2004 Year End Results Company reports revenues for 2004 of $6,758,535 with a net loss of ($0.06) per share. Neptune Technologies & Bioressources Inc. Reports Q3 Results Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004. Neptune Technologies & Bioressources Inc. Reports Q3 Results Company reports revenues of $1,292,460 compared to $601,576 prior year, with an EBITDA of $117,000 compared to a negative EBITDA of $240,000 in 2004. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Chr. Hansen opens new office in Colombia New premises is to be the cornerstone in the company’s aim to gain new market shares. Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement Company merging with FFG Industries, Inc. Technology Flavors & Fragrances, Inc. Enters into Definitive Merger Agreement Company merging with FFG Industries, Inc. Cargill and Diversa Sign Collaboration for Development of Novel Enzymes Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product. Cargill and Diversa Sign Collaboration for Development of Novel Enzymes Companies to collaborate to discover and develop novel enzymes for the cost- effective production of a proprietary product. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Dr. Reddy’s to Market Joint Supplement as Drug in India Company has formed a partnership with Cymbiotics, Inc. and Dr. Reddy’s Laboratories to launch Celadrin as a pharmaceutical in India. Fonterra Ends National Foods Offer and Divests Stake Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional. Fonterra Ends National Foods Offer and Divests Stake Fonterra announces it intends to withdraw onw offer and accept San Miguel Corporation’s offer of $6.40 per share, if that offer is unconditional. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. New Morning Corporation Appoints New Management and Director Company announces the departures of Thomas L. Crom and Philip Toy, and the appointment of new senior management and a director. VitaCube Completes Financing Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc. VitaCube Completes Financing Company has closed its offer of 1,500,000 units at $6.15 per unit for gross proceeds of $9,225,000,led by The Shemano Group, S.W. Bach & Company and Neidiger Tucker Bruner, Inc. John L. Cassis Joins Nutrition 21 Board Of Directors Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack. John L. Cassis Joins Nutrition 21 Board Of Directors Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack. John L. Cassis Joins Nutrition 21 Board Of Directors Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack. John L. Cassis Joins Nutrition 21 Board Of Directors Company announces that John L. Cassis has joined the Company's Board of Directors, succeeding Robert Pollack. Renaissance-Glykon HCA Agreement in Force Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force. Renaissance-Glykon HCA Agreement in Force Company has confirmed that exclusive licensing agreement with Glykon Technologies Group, LLC is in full force. Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd. Phosphagenics Ltd and Swisse Vitamins Pty Ltd reach agreement for Vitamin E phosphate Company signs deal to supply Vitamin E phosphate to Australian company Swisse Vitamins Pty Ltd. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. DSM Sells Bakery Ingredients Business to Gilde Transaction will include all activities of DSM Bakery Ingredients, with the exception of the business unit Baking Enzymes, which was transferred to DSM Food Specialties in 2004, and DSM Bakery Ingredients’ stake in a joint venture in South Africa. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. Swiss Medica Announces Vice President in Charge of Anti-Depression Biohealth Solutions Division Company announces appointment of Wendy Kramer as Vice President in charge of the Company's newly acquired Anti-Depression BioHealth Solutions division. CAROTECH BHD - Enroute to IPO on the Malaysian MESDAQ Company announces its initial public offering of 76,690,000 shares RM0.40 each. The listing is expected to raise RM30.7 million that will be used to repay borrowings and for working capital. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	DENVER, April 7, 2005 /PRNewswire-FirstCall via COMTEX/ -- Lifeline Therapeutics, Inc. (OTC Bulletin Board: LFLT), a health and nutrition company that is dedicated to extending "healthy life expectancy" through better antioxidant therapies, today announced that Dr. James D. Crapo will be joining the company's Board of Directors. Dr. Crapo brings nearly 30 years of experience in the health and science field to his new role. He served as the Chairman of Medicine at the National Jewish Medical and Research Center, from 1996, until his recent sabbatical in 2004. National Jewish is a top-rated private institution in immunology and allergic diseases and has been rated number one nationally in pulmonary medicine by U.S. News and World Report for the past 7 years. "We are thrilled to welcome Dr. Crapo to our Board of Directors," said Bill Driscoll, President and CEO of Lifeline Therapeutics. "His extensive work in antioxidant research, particularly with Superoxide Dismutase (SOD), will provide additional insight into fighting both oxidative stress and aging -- two key areas in which we hope to further research in an effort to better the lives of millions of people around the world." Dr. Crapo maintains a large research program focused on the role of oxidants and anti-oxidants in the causation and treatment of diseases. He was the first scientist to extend Dr. Fridovich and Dr. McCord's (Director of Science for Lifeline Therapeutics) original discovery of SOD to mammalian models of disease. SOD is the body's most powerful natural antioxidant. Prior to coming to National Jewish, Dr. Crapo spent over 15 years as the Chief of the Pulmonary and Critical Care Medicine Division at Duke University Medical Center. Throughout his professional career he has been active in numerous professional societies, including service on the NHLBI Advisory Council and serving as President of the American Thoracic Society and President of the Fleischner Society. Dr. Crapo said, "I have been involved in antioxidant research for decades. Lifeline's Protandim represents a significant breakthrough that has far-reaching implications and applications. I am truly excited to be involved with such promising research and products." Dr. Crapo has authored more than 200 original scientific publications, numerous book chapters and seven textbooks.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software